Mary Ann Liebert, Inc.’s Post

We’re pleased to welcome Wai Hong (Kevin) Lo, PhD, as the new Editor-in-Chief of ASSAY and Drug Development Technologies. Dr. Lo brings over 20 years of expertise in drug discovery and translational science, along with a strong editorial background. He shared his vision for the journal: "I plan to introduce innovative approaches, such as enhancing online accessibility, incorporating visuals and lay summaries, and increasing social media engagement. These efforts will help us reach a broader audience, making our content more engaging and relevant to diverse scientific and industrial communities." We also extend our gratitude to Bruce Melancon, PhD, for his outstanding service as Editor-in-Chief. Explore the journal: https://hubs.li/Q02YXnQm0 #Leadership #DrugDevelopment #Biotechnology #ASSAYJournal

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics